A Q2 2017 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q2 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.1B+8.1% YoY

Gross Profit

$592M53.7% margin

Operating Income

$201M18.2% margin

Net Income

$164M14.9% margin

EPS (Diluted)

$0.50

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

$257M

Free Cash Flow

$214M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$8.0B

Total Liabilities

$3.6B

Stockholders' Equity

$4.4B

Cash & Equivalents

$2.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+8.1%
Gross Profit	$592M	$530M	+11.7%
Operating Income	$201M	$131M	+53.4%
Net Income	$164M	$91M	+80.2%

Revenue Segments

Life Sciences and Applied Markets

$523M47%

Agilent CrossLab

$378M34%

Diagnostics and Genomics

$201M18%